Mar 14, 2024
Donor Selection Criteria for Adipose, Liver & Blood Procurement -- University of Minnesota Human TMC
- Sayeed Ikramuddin1,
- Laura Niedernhofer1
- 1University of Minnesota Medical School, Minneapolis, MN USA
Protocol Citation: Sayeed Ikramuddin, Laura Niedernhofer 2024. Donor Selection Criteria for Adipose, Liver & Blood Procurement -- University of Minnesota Human TMC. protocols.io https://dx.doi.org/10.17504/protocols.io.rm7vzxw4xgx1/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: March 14, 2024
Last Modified: March 14, 2024
Protocol Integer ID: 96726
Keywords: Adipose, Human, SenNet, criteria, UMN, UMinnesota, University of Minnesota, Niedernhofer, Donor criteria
Funders Acknowledgement:
NIH
Grant ID: 1U54AG07041-01
Abstract
This document outlines the inclusion and exclusion criteria for donors of adipose (visceral, subcutenous) and blood for the SenNet Consortium program from the University of Minnesota Human TMC (Niedernhofer).
Excerpt from the UMN IRB for Human Adipose procurement, section 8.0
Protocol title: Profiling of Adipose Tissue Depots and Immune Correlates
Last updated: 2/10/2023
Inclusion Criteria
Inclusion Criteria
Age 18 years old or older
Undergoing abdominal surgical procedure with general anesthesia
Written informed consent
Exclusion Criteria
Exclusion Criteria
Pregnancy or nursing -- Pregnancy is routinely an exclusion for surgery. If patients are scheduled for surgery, they receive a pregnancy test per clinical care. The study team will utilize the results available in the medical record to determine eligibility related to pregnancy status.
Exclusion at the discretion of attending physician or Eligibility Committee.
Screening
Screening
Potential participant identification will be completed by PI or delegated team members, as appropriate.Patients within the clinical practice, meeting all inclusion and none of the exclusion criteria, will be contacted by clinic staff to determine if they are possibly interested in the study. Eligible individuals that are interested in participating will be contacted by a research team member, either remotely or in-person, to review the study details and consent. Written consent will be confirmed before any further study activities are completed.
Vulnerable Populations
Vulnerable Populations
| Population / Group | Identify whether any of the following populations will be targeted, included (not necessarily targeted) or excluded from participation in the study. | |
| Children | Excluded from Participation | |
| Pregnant women/fetuses/neonates | Excluded from Participation | |
| Prisoners | Excluded from Participation | |
| Adults lacking capacity to consent and/or adults with diminished capacity to consent, including, but not limited to, those with acute medical conditions, psychiatric disorders, neurologic disorders, developmental disorders, and behavioral disorders | Excluded from Participation | |
| Non-English speakers | Included/Allowed to Participate | |
| Those unable to read (illiterate) | Included/Allowed to Participate | |
| Employees of the researcher | Included/Allowed to Participate | |
| Students of the researcher | Included/Allowed to Participate | |
| Undervalued or disenfranchised social group | Included/Allowed to Participate | |
| Active members of the military (service members), DoD personnel (including civilian employees) | Included/Allowed to Participate | |
| Individual or group that is disadvantaged in the distribution of social goods and services such as income, housing, or healthcare. | Included/Allowed to Participate | |
| Individual or group with a serious health condition for which there are no satisfactory standard treatments. | Included/Allowed to Participate | |
| Individual or group with a fear of negative consequences for not participating in the research (e.g. institutionalization, deportation, disclosure of stigmatizing behavior). | Included/Allowed to Participate | |
| Any other circumstance/dynamic that could increase vulnerability to coercion or exploitation that might influence consent to research or decision to continue in research. | Included/Allowed to Participate | |
| Individual or group that is approached for participation in research during a stressful situation such as emergency room setting, childbirth (labor), etc. | Included/Allowed to Participate |
This table identifies populations/groups of vulnerable populations and defines whether any of them will be targeted, included (but not necessarily targeted), or excluded from participation in the study/collection.
Additional Safeguards
Additional Safeguards
Individuals that checked in section 7.1 that fall under the definition of vulnerable populations may be included in the study in an effort to ensure that data collected is representative of the clinical population affected by this condition. These populations will not be targeted, but will be included if eligible for the study.
The following safeguards will be implemented to protect the rights and welfare of the groups listed below:
- Non-English speakers: Guidance regarding the short form consent process will be followed as listed in Section 20.4 below.
- Those unable to read (illiterate): The consent form will be read to these individuals and they will be asked to make their mark on the consent form. A witness will be present during the consent discussion and will also sign the consent form.
- Employees of the researcher: If an employee of the researcher is eligible for the study, a member of the study team that is not the employee’s supervisor will obtain consent.
- Students of the researcher: If a student of the researcher is eligible for the study, a member of the study team who does not have a student/instructor relationship with the student will obtain consent.